ATLAS: Ambulatory Treatments for Leakage Associated With Stress

Sponsor
NICHD Pelvic Floor Disorders Network (Other)
Overall Status
Completed
CT.gov ID
NCT00270998
Collaborator
(none)
445
8
3
42
55.6
1.3

Study Details

Study Description

Brief Summary

Stress urinary incontinence is the uncontrollable leakage of urine with physical effort or stress, such as coughing, sneezing, or exercise. Treatment for stress incontinence can be surgical or non-surgical. Different non-surgical treatments include pelvic muscle exercises and pessary use. Pelvic muscle exercises (often known as "Kegel" exercises) train and strengthen the pelvic muscles and improve incontinence. A pessary is a medical device that fits inside the vagina to give the urethra and bladder extra support and prevent or reduce urinary incontinence. Exercises and pessary use can help women with stress incontinence but it is not known which treatment is better, or if a combination of the two treatments at the same time is best. This study will determine whether pelvic muscle training and exercises, pessary use, or a combination of both exercises and pessary is most effective at improving incontinence in women. The study's primary hypothesis is that pessary use is more effective than pelvic muscle exercises after 3 months of treatment.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Behavioral Therapy
  • Device: Intravaginal Pessary
  • Device: Pessary combined with behavioral therapy
Phase 3

Detailed Description

Women commonly have symptoms of stress urinary incontinence (leakage with physical stress such as coughing or sneezing) and urinary urgency or urge incontinence (leakage associated with the overwhelming urge to urinate). Non-surgical treatment is usually offered as first-line therapy, such as pelvic muscle exercises ("Kegel" exercises) or pessary use. A pessary is a small ring that fits inside the vagina. Pelvic muscle training and exercises may help incontinence by increased awareness and strength of the muscles that are used in holding the urethra closed. Pessary use may help incontinence by providing more support to the bladder and urethra. Both treatments can be helpful in reducing or eliminating incontinence, but it is not known which treatment is better. The study will compare the level of improvement with pelvic muscle exercises, pessary use, and a combination of both exercises and pessary.

Women with stress or mixed urinary incontinence will be randomly assigned to 1 of 3 groups:

(1) pelvic muscle training and exercises; (2) pessary use; and (3) both exercises and pessary. Women in the exercises groups will have 4 visits over 8 weeks with a specially trained therapist for pelvic muscle training and exercises. Women in the pessary group will be fitted with a pessary to be worn continuously. Assessments will include questionnaires, bladder diary, and physical examination. Follow-up evaluations occur at 3 months, 6 months (by telephone only), and 1 year after initial treatment.

Comparisons: The level of improvement after treatment will be compared in the 3 groups. In addition, women in the 3 groups will record the number of accidental leakage episodes by bladder diary; and the frequency of those episodes will be compared in the 3 groups. Other aspects of health, including health-related quality of life, will be compared in the 3 groups.

Study Design

Study Type:
Interventional
Actual Enrollment :
445 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
ATLAS: Ambulatory Treatments for Leakage Associated With Stress, A Randomized Trial of Pelvic Muscle Exercise Versus Incontinence Pessary Versus Both for Women With Stress or Mixed Urinary Incontinence
Study Start Date :
Jun 1, 2005
Actual Primary Completion Date :
Dec 1, 2008
Actual Study Completion Date :
Dec 1, 2008

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intravaginal Pessary

Pessary restores continence by stabilization of the proximal urethra and urethrovesical junction, facilitating pressure transmission to the proximal urethra.

Device: Intravaginal Pessary
Intravaginal pessary

Experimental: Behavioral Therapy

Pelvic floor muscle training and exercise which includes strong contraction of the pelvic floor muscles to prevent incontinence by occluding the urethra and regular practice can improve pelvic muscle support.

Behavioral: Behavioral Therapy
Pelvic muscle training and exercises

Experimental: Pessary combined with behavioral therapy

Combination of the explanations above.

Device: Pessary combined with behavioral therapy
Intravaginal pessary and behavioral therapy

Outcome Measures

Primary Outcome Measures

  1. "Much Better" or "Very Much Better" on PGI-I at 3 Months [Outcome was measured at three months following randomization.]

    PGI-I, Patient Global Impression of Improvement, is a five-point scale that ranges from "not at all" to "very much better." Participants were considered a success if they responded "much better" or "very much better," or a failure if they responded otherwise.

  2. No Bothersome Stress Incontinence Symptoms at 3 Months [Outcome was measured at three months following randomization.]

    Success if participants answer either "no" or "yes" with a bother component of "not at all" or "somewhat" to all seven Urogenital Distress Inventory-Stress Incontinence Subscale items of the Pelvic Floor Distress Inventory, or a failure if they responded otherwise.

Secondary Outcome Measures

  1. "Much Better" or "Very Much Better" on PGI-I at 12 Months [Outcome was measured at 12 months following randomization.]

    PGI-I, Patient Global Impression of Improvement, is a five-point scale that ranges from "not at all" to "very much better." Participants were considered a success if they responded "much better" or "very much better," or a failure if they responded otherwise.

  2. No Bothersome Stress Incontinence Symptoms at 12 Months. [Outcome was measured at 12 months following randomization.]

    Success if participants answer either "no" or "yes" with a bother component of "not at all" or "somewhat" to all seven Urogenital Distress Inventory-Stress Incontinence Subscale items of the Pelvic Floor Distress Inventory, or a failure if they responded otherwise.

  3. 75% Reduction in Weekly Urinary Incontinence Episodes at 3 Months [Outcome was measured at three months following randomization.]

    Success if participants reported at least 75% reduction in frequency of incontinence episodes on 7-day bladder diary, a failure if they reported otherwise.

  4. 75% Reduction in Weekly Urinary Incontinence Episodes at 12 Months [Outcome was measured at 12 months following randomization.]

    Success if participants reported at least 75% reduction in frequency of incontinence episodes on 7-day bladder diary, a failure if they reported otherwise.

  5. Satisfaction With Treatment at 3 Months [Outcome was measured at three months following randomization.]

    Success if participant reported being "satisfied" on Patient Satisfaction Question (PSQ), a failure if they reported otherwise.

  6. Satisfaction With Treatment at 12 Months [Outcome was measured at 12 months following randomization.]

    Success if participant reported being "satisfied" on Patient Satisfaction Question (PSQ), a failure if they reported otherwise.

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Stress urinary incontinence or stress-predominant mixed urinary incontinence, with at least 2 episodes of stress incontinence on 7-day bladder diary and the number of stress incontinence episodes exceeding the number of urge incontinence episodes.

  • Urinary incontinence for at least three months.

  • Ambulatory adult women.

  • Stage 0-I-II pelvic organ prolapse.

Exclusion Criteria:
  • Continual urine leakage.

  • Pregnancy or planning pregnancy within 1 year.

  • Active urinary tract infection.

  • Urinary retention.

  • Currently on medication for incontinence.

  • Currently using a pessary.

  • Neurologic condition that affects bladder function.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Alabama Birmingham Alabama United States 35249
2 University of California, San Diego Medical Center La Jolla California United States 92037
3 Loyola University Maywood Illinois United States 60153
4 University of North Carolina Chapel Hill North Carolina United States 27599
5 Duke University Durham North Carolina United States 27710
6 Cleveland Clinic Cleveland Ohio United States 44195
7 University of Texas Southwestern Dallas Texas United States 75390
8 University of Utah Salt Lake City Utah United States 84132

Sponsors and Collaborators

  • NICHD Pelvic Floor Disorders Network

Investigators

  • Study Chair: Holly E Richter, PhD, MD, University of Alabama at Birmingham

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
NICHD Pelvic Floor Disorders Network
ClinicalTrials.gov Identifier:
NCT00270998
Other Study ID Numbers:
  • PFDN 13
First Posted:
Dec 29, 2005
Last Update Posted:
May 30, 2018
Last Verified:
Apr 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Keywords provided by NICHD Pelvic Floor Disorders Network
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details 740 women were screened for symptoms of stress only or mixed incontinence symptoms and age of at least 18 years old. 294 did not meet inclusion criteria, one refused to participate and 445 were enrolled.
Pre-assignment Detail
Arm/Group Title Pessary Behavioral Therapy Combination of Pessary and Behavioral Therapy
Arm/Group Description Intravaginal incontinence pessary Pelvic muscle training and exercises Treatment is a combination of both pessary and pelvic muscle exercises
Period Title: 3 Month Follow-up
STARTED 149 146 150
COMPLETED 110 124 132
NOT COMPLETED 39 22 18
Period Title: 3 Month Follow-up
STARTED 110 124 132
COMPLETED 96 99 111
NOT COMPLETED 14 25 21

Baseline Characteristics

Arm/Group Title Pessary Behavioral Therapy Combination of Pessary and Behavioral Therapy Total
Arm/Group Description Intravaginal pessary Pelvic muscle training and exercises Treatment includes a combination of both pessary and pelvic muscle exercises Total of all reporting groups
Overall Participants 149 146 150 445
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
50.2
(11.0)
49.6
(13.0)
49.5
(11.8)
49.8
(11.9)
Sex/Gender, Customized (Count of Participants)
Female
149
100%
146
100%
150
100%
445
100%
Race/Ethnicity, Customized (Count of Participants)
White or Caucasian
126
84.6%
132
90.4%
122
81.3%
380
85.4%
Black or African American
15
10.1%
10
6.8%
20
13.3%
45
10.1%
Other
8
5.4%
4
2.7%
8
5.3%
20
4.5%
Vaginal Deliveries (deliveries) [Median (Inter-Quartile Range) ]
Median (Inter-Quartile Range) [deliveries]
2
2
2
2
Menstrual Status (Count of Participants)
Pre-menopausal
75
50.3%
71
48.6%
68
45.3%
214
48.1%
Post-menopausal
60
40.3%
62
42.5%
66
44%
188
42.2%
Not sure
14
9.4%
13
8.9%
16
10.7%
43
9.7%
Prior Nonsurgical UI (Count of Participants)
Count of Participants [Participants]
30
20.1%
35
24%
27
18%
92
20.7%
Prior UI Surgery (Count of Participants)
Count of Participants [Participants]
10
6.7%
7
4.8%
10
6.7%
27
6.1%
Hysterectomy (Count of Participants)
Count of Participants [Participants]
39
26.2%
39
26.7%
32
21.3%
110
24.7%
Incontinence Type (Count of Participants)
Stress Only
69
46.3%
65
44.5%
70
46.7%
204
45.8%
Mixed
80
53.7%
81
55.5%
80
53.3%
241
54.2%
Incontinence Frequency (Count of Participants)
14 or more episodes per wk
68
45.6%
67
45.9%
67
44.7%
202
45.4%
Fewer than 14 episodes per wk
81
54.4%
79
54.1%
83
55.3%
243
54.6%
Currently Receiving Estrogen Therapy (Count of Participants)
Count of Participants [Participants]
27
18.1%
24
16.4%
16
10.7%
67
15.1%

Outcome Measures

1. Primary Outcome
Title "Much Better" or "Very Much Better" on PGI-I at 3 Months
Description PGI-I, Patient Global Impression of Improvement, is a five-point scale that ranges from "not at all" to "very much better." Participants were considered a success if they responded "much better" or "very much better," or a failure if they responded otherwise.
Time Frame Outcome was measured at three months following randomization.

Outcome Measure Data

Analysis Population Description
If participant did not attend the three-month follow-up, missing values were imputed by either the value from the next available follow-up or if the participant was lost to follow-up the participant was treated as a failure.
Arm/Group Title Pessary Behavioral Therapy Combination of Pessary and Behavioral Therapy
Arm/Group Description Intravaginal pessary Pelvic muscle training and exercises Treatment includes a combination of both pessary and pelvic muscle exercises
Measure Participants 149 146 150
Count of Participants [Participants]
80
53.7%
72
49.3%
59
39.3%
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Pessary, Behavioral Therapy
Comments A priori, the combination treatment was considered superior (75% success rate) to either single-modality therapy (60% success rate) at 80% power with 150 participants per group.
Type of Statistical Test Non-Inferiority
Comments Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.
Statistical Test of Hypothesis p-Value <0.0492
Comments A priori threshold for statistical significance set at p = 0.0492 to account for interim analysis
Method Regression, Logistic
Comments
Statistical Analysis 2
Statistical Analysis Overview Comparison Group Selection Pessary, Combination of Pessary and Behavioral Therapy
Comments A priori, the combination treatment was considered superior (75% success rate) to either single-modality therapy (60% success rate) at 80% power with 150 participants per group.
Type of Statistical Test Non-Inferiority
Comments Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.
Statistical Test of Hypothesis p-Value 0.02
Comments A priori threshold for statistical significance set at p = 0.0492 to account for interim analysis
Method Regression, Logistic
Comments
Statistical Analysis 3
Statistical Analysis Overview Comparison Group Selection Behavioral Therapy, Combination of Pessary and Behavioral Therapy
Comments A priori, the combination treatment was considered superior (75% success rate) to either single-modality therapy (60% success rate) at 80% power with 150 participants per group.
Type of Statistical Test Non-Inferiority
Comments Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.
Statistical Test of Hypothesis p-Value 0.49
Comments A priori threshold for statistical significance set at p = 0.0492 to account for interim analysis
Method Regression, Logistic
Comments
2. Primary Outcome
Title No Bothersome Stress Incontinence Symptoms at 3 Months
Description Success if participants answer either "no" or "yes" with a bother component of "not at all" or "somewhat" to all seven Urogenital Distress Inventory-Stress Incontinence Subscale items of the Pelvic Floor Distress Inventory, or a failure if they responded otherwise.
Time Frame Outcome was measured at three months following randomization.

Outcome Measure Data

Analysis Population Description
If participant did not attend the three-month follow-up, missing values were imputed by either the value from the next available follow-up or if the participant was lost to follow-up the participant was treated as a failure.
Arm/Group Title Pessary Behavioral Therapy Combination of Pessary and Behavioral Therapy
Arm/Group Description Intravaginal incontinence pessary Pelvic muscle training and exercises Treatment is a combination of both pessary and pelvic muscle exercises
Measure Participants 149 146 150
Count of Participants [Participants]
66
44.3%
71
48.6%
49
32.7%
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Pessary, Behavioral Therapy
Comments
Type of Statistical Test Non-Inferiority
Comments Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.
Statistical Test of Hypothesis p-Value 0.006
Comments
Method Regression, Logistic
Comments
Statistical Analysis 2
Statistical Analysis Overview Comparison Group Selection Pessary, Combination of Pessary and Behavioral Therapy
Comments
Type of Statistical Test Non-Inferiority
Comments Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.
Statistical Test of Hypothesis p-Value 0.048
Comments
Method Regression, Logistic
Comments
Statistical Analysis 3
Statistical Analysis Overview Comparison Group Selection Behavioral Therapy, Combination of Pessary and Behavioral Therapy
Comments
Type of Statistical Test Non-Inferiority
Comments Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.
Statistical Test of Hypothesis p-Value 0.42
Comments
Method Regression, Logistic
Comments
3. Secondary Outcome
Title "Much Better" or "Very Much Better" on PGI-I at 12 Months
Description PGI-I, Patient Global Impression of Improvement, is a five-point scale that ranges from "not at all" to "very much better." Participants were considered a success if they responded "much better" or "very much better," or a failure if they responded otherwise.
Time Frame Outcome was measured at 12 months following randomization.

Outcome Measure Data

Analysis Population Description
If participant did not attend the 12-month follow-up, missing values were imputed as a failure.
Arm/Group Title Pessary Behavioral Therapy Combination of Pessary and Behavioral Therapy
Arm/Group Description Intravaginal incontinence pessary Pelvic muscle training and exercises Treatment is a combination of both pessary and pelvic muscle exercises
Measure Participants 149 146 150
Count of Participants [Participants]
49
32.9%
48
32.9%
47
31.3%
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Pessary, Behavioral Therapy
Comments
Type of Statistical Test Non-Inferiority
Comments Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.
Statistical Test of Hypothesis p-Value <0.0492
Comments
Method Regression, Logistic
Comments
Statistical Analysis 2
Statistical Analysis Overview Comparison Group Selection Pessary, Combination of Pessary and Behavioral Therapy
Comments
Type of Statistical Test Non-Inferiority
Comments Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.
Statistical Test of Hypothesis p-Value <0.0492
Comments
Method Regression, Logistic
Comments
Statistical Analysis 3
Statistical Analysis Overview Comparison Group Selection Behavioral Therapy, Combination of Pessary and Behavioral Therapy
Comments
Type of Statistical Test Non-Inferiority
Comments Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.
Statistical Test of Hypothesis p-Value <0.0492
Comments
Method Regression, Logistic
Comments
4. Secondary Outcome
Title No Bothersome Stress Incontinence Symptoms at 12 Months.
Description Success if participants answer either "no" or "yes" with a bother component of "not at all" or "somewhat" to all seven Urogenital Distress Inventory-Stress Incontinence Subscale items of the Pelvic Floor Distress Inventory, or a failure if they responded otherwise.
Time Frame Outcome was measured at 12 months following randomization.

Outcome Measure Data

Analysis Population Description
If participant did not attend the 12-month follow-up, missing values were imputed as a failure.
Arm/Group Title Pessary Behavioral Therapy Combination of Pessary and Behavioral Therapy
Arm/Group Description Intravaginal incontinence pessary Pelvic muscle training and exercises Treatment is a combination of both pessary and pelvic muscle exercises
Measure Participants 149 146 150
Count of Participants [Participants]
49
32.9%
59
40.4%
52
34.7%
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Pessary, Behavioral Therapy
Comments
Type of Statistical Test Non-Inferiority
Comments Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.
Statistical Test of Hypothesis p-Value <0.0492
Comments
Method Regression, Logistic
Comments
Statistical Analysis 2
Statistical Analysis Overview Comparison Group Selection Pessary, Combination of Pessary and Behavioral Therapy
Comments
Type of Statistical Test Non-Inferiority
Comments Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.
Statistical Test of Hypothesis p-Value <0.0492
Comments
Method Regression, Logistic
Comments
Statistical Analysis 3
Statistical Analysis Overview Comparison Group Selection Behavioral Therapy, Combination of Pessary and Behavioral Therapy
Comments
Type of Statistical Test Non-Inferiority
Comments Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.
Statistical Test of Hypothesis p-Value <0.0492
Comments
Method Regression, Logistic
Comments
5. Secondary Outcome
Title 75% Reduction in Weekly Urinary Incontinence Episodes at 3 Months
Description Success if participants reported at least 75% reduction in frequency of incontinence episodes on 7-day bladder diary, a failure if they reported otherwise.
Time Frame Outcome was measured at three months following randomization.

Outcome Measure Data

Analysis Population Description
If participant did not attend the three-month follow-up, missing values were imputed by either the value from the next available follow-up or if the participant was lost to follow-up the participant was treated as a failure.
Arm/Group Title Pessary Behavioral Therapy Combination of Pessary and Behavioral Therapy
Arm/Group Description Intravaginal incontinence pessary Pelvic muscle training and exercises Treatment is a combination of both pessary and pelvic muscle exercises
Measure Participants 149 146 150
Count of Participants [Participants]
80
53.7%
68
46.6%
69
46%
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Pessary, Behavioral Therapy
Comments
Type of Statistical Test Non-Inferiority
Comments Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.
Statistical Test of Hypothesis p-Value <0.0492
Comments
Method Regression, Logistic
Comments
Statistical Analysis 2
Statistical Analysis Overview Comparison Group Selection Pessary, Combination of Pessary and Behavioral Therapy
Comments
Type of Statistical Test Non-Inferiority
Comments Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.
Statistical Test of Hypothesis p-Value <0.0492
Comments
Method Regression, Logistic
Comments
Statistical Analysis 3
Statistical Analysis Overview Comparison Group Selection Behavioral Therapy, Combination of Pessary and Behavioral Therapy
Comments
Type of Statistical Test Non-Inferiority
Comments Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.
Statistical Test of Hypothesis p-Value <0.0492
Comments
Method Regression, Logistic
Comments
6. Secondary Outcome
Title 75% Reduction in Weekly Urinary Incontinence Episodes at 12 Months
Description Success if participants reported at least 75% reduction in frequency of incontinence episodes on 7-day bladder diary, a failure if they reported otherwise.
Time Frame Outcome was measured at 12 months following randomization.

Outcome Measure Data

Analysis Population Description
If participant did not attend the 12-month follow-up, missing values were imputed as a failure.
Arm/Group Title Pessary Behavioral Therapy Combination of Pessary and Behavioral Therapy
Arm/Group Description Intravaginal incontinence pessary Pelvic muscle training and exercises Treatment is a combination of both pessary and pelvic muscle exercises
Measure Participants 149 146 150
Count of Participants [Participants]
52
34.9%
54
37%
51
34%
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Pessary, Behavioral Therapy
Comments
Type of Statistical Test Non-Inferiority
Comments Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.
Statistical Test of Hypothesis p-Value <0.0492
Comments
Method Regression, Logistic
Comments
Statistical Analysis 2
Statistical Analysis Overview Comparison Group Selection Pessary, Combination of Pessary and Behavioral Therapy
Comments
Type of Statistical Test Non-Inferiority
Comments Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.
Statistical Test of Hypothesis p-Value <0.0492
Comments
Method Regression, Logistic
Comments
Statistical Analysis 3
Statistical Analysis Overview Comparison Group Selection Behavioral Therapy, Combination of Pessary and Behavioral Therapy
Comments
Type of Statistical Test Non-Inferiority
Comments Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.
Statistical Test of Hypothesis p-Value <0.0492
Comments
Method Regression, Logistic
Comments
7. Secondary Outcome
Title Satisfaction With Treatment at 3 Months
Description Success if participant reported being "satisfied" on Patient Satisfaction Question (PSQ), a failure if they reported otherwise.
Time Frame Outcome was measured at three months following randomization.

Outcome Measure Data

Analysis Population Description
If participant did not attend the three-month follow-up, missing values were imputed by either the value from the next available follow-up or if the participant was lost to follow-up the participant was treated as a failure.
Arm/Group Title Pessary Behavioral Therapy Combination of Pessary and Behavioral Therapy
Arm/Group Description Intravaginal incontinence pessary Pelvic muscle training and exercises Treatment is a combination of both pessary and pelvic muscle exercises
Measure Participants 149 146 150
Count of Participants [Participants]
118
79.2%
110
75.3%
94
62.7%
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Pessary, Behavioral Therapy
Comments
Type of Statistical Test Non-Inferiority
Comments Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.
Statistical Test of Hypothesis p-Value 0.03
Comments
Method Regression, Logistic
Comments
Statistical Analysis 2
Statistical Analysis Overview Comparison Group Selection Pessary, Combination of Pessary and Behavioral Therapy
Comments
Type of Statistical Test Non-Inferiority
Comments Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.
Statistical Test of Hypothesis p-Value 0.048
Comments
Method Regression, Logistic
Comments
Statistical Analysis 3
Statistical Analysis Overview Comparison Group Selection Behavioral Therapy, Combination of Pessary and Behavioral Therapy
Comments
Type of Statistical Test Non-Inferiority
Comments Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.
Statistical Test of Hypothesis p-Value <0.0492
Comments
Method Regression, Logistic
Comments
8. Secondary Outcome
Title Satisfaction With Treatment at 12 Months
Description Success if participant reported being "satisfied" on Patient Satisfaction Question (PSQ), a failure if they reported otherwise.
Time Frame Outcome was measured at 12 months following randomization.

Outcome Measure Data

Analysis Population Description
If participant did not attend the 12-month follow-up, missing values were imputed as a failure.
Arm/Group Title Pessary Behavioral Therapy Combination of Pessary and Behavioral Therapy
Arm/Group Description Intravaginal incontinence pessary Pelvic muscle training and exercises Treatment is a combination of both pessary and pelvic muscle exercises
Measure Participants 149 146 150
Count of Participants [Participants]
81
54.4%
79
54.1%
75
50%
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Pessary, Behavioral Therapy
Comments
Type of Statistical Test Non-Inferiority
Comments Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.
Statistical Test of Hypothesis p-Value <0.0492
Comments
Method Regression, Logistic
Comments
Statistical Analysis 2
Statistical Analysis Overview Comparison Group Selection Pessary, Combination of Pessary and Behavioral Therapy
Comments
Type of Statistical Test Non-Inferiority
Comments Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.
Statistical Test of Hypothesis p-Value <0.0492
Comments
Method Regression, Logistic
Comments
Statistical Analysis 3
Statistical Analysis Overview Comparison Group Selection Behavioral Therapy, Combination of Pessary and Behavioral Therapy
Comments
Type of Statistical Test Non-Inferiority
Comments Logistic regression was used to adjust for randomization stratification variables of incontinence type and incontinence severity. No parameter estimates were reported. No adjustments for multiple comparisons made.
Statistical Test of Hypothesis p-Value <0.0492
Comments
Method Regression, Logistic
Comments

Adverse Events

Time Frame Adverse events were collected during treatment visits over an 8-week treatment period.
Adverse Event Reporting Description As no other adverse events, those that don't meet the definition of a SAE, occurred in at least 5% of participants in any one of the three arms for the ATLAS trial, no table was generated as it is not required by law.
Arm/Group Title Pessary Behavioral Therapy Combination of Pessary and Behavioral Therapy
Arm/Group Description Intravaginal incontinence pessary Pelvic muscle training and exercises Treatment is a combination of both pessary and pelvic muscle exercises
All Cause Mortality
Pessary Behavioral Therapy Combination of Pessary and Behavioral Therapy
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total / (NaN) / (NaN) / (NaN)
Serious Adverse Events
Pessary Behavioral Therapy Combination of Pessary and Behavioral Therapy
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 7/149 (4.7%) 4/146 (2.7%) 6/150 (4%)
Cardiac disorders
Angioplasty of heart 1/149 (0.7%) 1 0/146 (0%) 0 1/150 (0.7%) 1
Gastrointestinal disorders
Cholecystectomy 0/149 (0%) 0 2/146 (1.4%) 2 0/150 (0%) 0
Hiatal hernia repair 1/149 (0.7%) 1 0/146 (0%) 0 0/150 (0%) 0
Left femoral hernia 1/149 (0.7%) 1 0/146 (0%) 0 0/150 (0%) 0
Musculoskeletal and connective tissue disorders
Fractured right leg and ankle 1/149 (0.7%) 1 0/146 (0%) 0 0/150 (0%) 0
Lumbar decompression surgery 1/149 (0.7%) 1 0/146 (0%) 0 0/150 (0%) 0
Right knee surgery 0/149 (0%) 0 1/146 (0.7%) 1 0/150 (0%) 0
Nervous system disorders
Left eye surgery for cancer 0/149 (0%) 0 0/146 (0%) 0 1/150 (0.7%) 1
Non-cardiac chest pain and anxiety 0/149 (0%) 0 0/146 (0%) 0 1/150 (0.7%) 1
Renal and urinary disorders
Urinary incontinence surgery 2/149 (1.3%) 2 0/146 (0%) 0 2/150 (1.3%) 2
Kidney surgery 0/149 (0%) 0 0/146 (0%) 0 1/150 (0.7%) 1
Uterine cancer 0/149 (0%) 0 0/146 (0%) 0 1/150 (0.7%) 1
Reproductive system and breast disorders
Oophorectomy 1/149 (0.7%) 1 0/146 (0%) 0 0/150 (0%) 0
Respiratory, thoracic and mediastinal disorders
Pneumonia 1/149 (0.7%) 1 0/146 (0%) 0 0/150 (0%) 0
Vascular disorders
Deep vein thrombosis 0/149 (0%) 0 1/146 (0.7%) 1 0/150 (0%) 0
Other (Not Including Serious) Adverse Events
Pessary Behavioral Therapy Combination of Pessary and Behavioral Therapy
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/149 (0%) 0/146 (0%) 0/150 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Marie Gantz
Organization RTI International
Phone 919-597-5110
Email mgantz@rti.org
Responsible Party:
NICHD Pelvic Floor Disorders Network
ClinicalTrials.gov Identifier:
NCT00270998
Other Study ID Numbers:
  • PFDN 13
First Posted:
Dec 29, 2005
Last Update Posted:
May 30, 2018
Last Verified:
Apr 1, 2018